Lentiginous eruption due to topical immunotherapy.
Tosti
Antonella
A
Piraccini
Bianca Maria
BM
Misciali
Cosimo
C
Vincenzi
Colombina
C
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000293:Adolescent; D000506:Alopecia Areata / Q000188:drug therapy*; D003503:Cyclobutanes / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007911:Lentigo / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008544:Melanocytes / Q000473:pathology
D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; C020637:squaric acid dibutyl ester